Adma Biologics reported $191.46M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
Adma Biologics USD 191.46M 21.22M Jun/2025
Alnylam Pharmaceuticals USD 71.69M 6.11M Jun/2025
Dynavax Technologies USD 75.69M 1.28M Jun/2025
Takeda JPY 1.24T 23.33B Jun/2025